This inventor holds 4 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Csl Behring Gmbh, Julius-Maximilians-Universitat Wurzburg. Active years: 2012-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Würzburg, DE (2012)
- Eibelstadt, DE (2014 - 2021)
Company Filing History:
Years Active: 2012-2021
Title: The Innovations of Bernhard Nieswandt
Introduction
Bernhard Nieswandt is a notable inventor based in Eibelstadt, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of thrombotic diseases and central nervous system disorders. With a total of 4 patents to his name, Nieswandt's work has the potential to impact many lives.
Latest Patents
Nieswandt's latest patents include a soluble glycoprotein V for treating thrombotic diseases. This invention involves a soluble polypeptide comprising a modified glycoprotein V (GPV) that lacks a functional transmembrane domain. It is designed for use in the treatment or prevention of thrombotic diseases by administering an effective amount of the soluble polypeptide to a subject. Another significant patent is the use of a C1-inhibitor for the treatment of secondary edema of the central nervous system. This invention focuses on preventing and/or treating secondary edema, particularly in cases of stroke, traumatic brain injury, and spinal cord injury. It also addresses disorders associated with increased permeability of the blood-brain barrier. Additionally, Nieswandt has developed a plasma-derived C1-inhibitor aimed at preventing, reducing, or treating brain ischemia-reperfusion injury.
Career Highlights
Throughout his career, Bernhard Nieswandt has worked with prominent organizations such as CSL Behring GmbH and Julius-Maximilians-Universität Würzburg. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nieswandt has collaborated with notable individuals, including Thomas Renné and Thomas Renne. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Bernhard Nieswandt's innovative work in the medical field, particularly through his patents, showcases his dedication to improving treatment options for serious health conditions. His contributions are likely to have a lasting impact on medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile